Cologne, Germany, July 9, 2013 / B3C newswire / -Blackfield announced today that it has entered a collaboration with AstraZeneca, a global biopharmaceutical company. Under the terms of the agreement, ...
Under the terms of the agreement, Blackfield will apply its genomics technologies and computational biology capabilities to validate preclinical models in support of one of AstraZeneca’s oncology drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results